Literature DB >> 15507413

Dysplastic nodules in liver cirrhosis: detection with triple phase helical dynamic CT.

J H Lim1, M J Kim, C K Park, S S Kang, W J Lee, H K Lim.   

Abstract

The purpose of this study was to determine the sensitivity of triple phase helical dynamic CT for detecting dysplastic nodules in patients with liver cirrhosis. 76 dysplastic nodules were confirmed by histopathological examination of the liver specimens after surgical resection in 21 patients or after explantation of the whole liver in 20 patients. Triple phase helical dynamic CT including arterial, portal venous and delayed phases was performed as a pre-operative evaluation for hepatocellular carcinoma. Two readers retrospectively evaluated the images. The presence of dysplastic nodules was determined by one-to-one correlation of the CT images and the pathological results in terms of the anatomical location and size of each nodule. Helical dynamic triple phase CT depicted eight of 76 dysplastic nodules (10%): five of 35 high grade dysplastic nodules (14%) and three of 41 low grade dysplastic nodules (7%). Triple phase helical dynamic CT is insensitive for detection of dysplastic nodules in cirrhotic livers.

Entities:  

Mesh:

Year:  2004        PMID: 15507413     DOI: 10.1259/bjr/56713551

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  13 in total

Review 1.  Solid liver masses: approach to management from the standpoint of a radiologist.

Authors:  Robert Garrett
Journal:  Curr Gastroenterol Rep       Date:  2013-12

2.  Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation.

Authors:  A Lam; D Fernando; C C Sirlin; M Nayyar; S C Goodwin; D K Imagawa; C Lall
Journal:  Clin Radiol       Date:  2017-08-02       Impact factor: 2.350

3.  Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule.

Authors:  Kazuhiro Saito; Fuminori Moriyasu; Katsutoshi Sugimoto; Ryota Nishio; Toru Saguchi; Toshitaka Nagao; Junichi Taira; Soichi Akata; Koichi Tokuuye
Journal:  World J Gastroenterol       Date:  2011-08-14       Impact factor: 5.742

Review 4.  Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.

Authors:  Myeong-Jin Kim; Sunyoung Lee; Chansik An
Journal:  Eur Radiol       Date:  2019-02-20       Impact factor: 5.315

5.  Assessment of hemodynamics in precancerous lesion of hepatocellular carcinoma: evaluation with MR perfusion.

Authors:  Sheng Guan; Wei-Dong Zhao; Kang-Rong Zhou; Wei-Jun Peng; Feng Tang; Jian Mao
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

6.  Does the echogenicity of focal liver lesions on baseline gray-scale ultrasound interfere with the diagnostic performance of contrast-enhanced ultrasound?

Authors:  Guang-Jian Liu; Hui-Xiong Xu; Xiao-Yan Xie; Zuo-Feng Xu; Yan-Ling Zheng; Jin-Yu Liang; Ming-De Lu; Fuminori Moriyasu
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

7.  Radiofrequency ablation of high-grade dysplastic nodules in chronic liver disease: comparison with well-differentiated hepatocellular carcinoma based on long-term results.

Authors:  Seong Hyun Kim; Hyo K Lim; Min Ju Kim; Dongil Choi; Hyunchul Rhim; Cheol Keun Park
Journal:  Eur Radiol       Date:  2007-12-14       Impact factor: 5.315

8.  SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings.

Authors:  Seong Hyun Kim; Won Jae Lee; Hyo K Lim; Cheol Keun Park
Journal:  Korean J Radiol       Date:  2009-03-03       Impact factor: 3.500

Review 9.  How to Differentiate Borderline Hepatic Nodules in Hepatocarcinogenesis: Emphasis on Imaging Diagnosis.

Authors:  Hyun Jeong Park; Byung Ihn Choi; Eun Sun Lee; Sung Bin Park; Jong Beum Lee
Journal:  Liver Cancer       Date:  2017-03-09       Impact factor: 11.740

10.  Development of an AI system for accurately diagnose hepatocellular carcinoma from computed tomography imaging data.

Authors:  Meiyun Wang; Fangfang Fu; Bingjie Zheng; Yan Bai; Qingxia Wu; Jianqiang Wu; Lin Sun; Qiuyu Liu; Mingge Liu; Yichen Yang; Hongru Shen; Dalu Kong; Xiaoyue Ma; Peiting You; Xiangchun Li; Fei Tian
Journal:  Br J Cancer       Date:  2021-08-07       Impact factor: 9.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.